Clinical Trial Update: 4D-310 in Adults With Fabry Disease and Cardiac Involvement [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating 4D-310 in adults with Fabry disease and cardiac involvement is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• 4D-310

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: Fabry Disease | Phase 1, Phase 2 | Status: RECRUITING